Kinesio Taping and Inhibitory Treatment Techniques
Not Applicable
Suspended
- Conditions
- Fibromyalgia
- Registration Number
- NCT02859467
- Lead Sponsor
- Universidad de Almeria
- Brief Summary
Objective: Compare the benefits of Kinesio Taping and Inhibitory Treatment Techniques for Cervical, Thoracic and Lumbar Spine in Patients with Fibromyalgia Syndrome (FMS).
Study Design: A single-blind randomized controlled trial was conducted on patients with FMS.
Setting: Clinical setting. Methods: Sixty-four subjects with FMS were randomly assigned to an experimental group receiving kinesio taping and inhibitory treatment techniques, or to a control group for exercises and electrical stimulation therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- SUSPENDED
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
- Diagnosed Fibromyalgia Syndrome.
- Limitation of usual activities due to pain on at least 1 day in the previous 30 days.
- Agreement to attend evening therapy sessions.
- Non-practice of regular physical activity.
Exclusion Criteria
- A history of surgery.
- The presence of comorbid conditions (e.g., morbid obesity, inflammatory diseases, irritable bowel syndrome and interstitial cystitis).
- A history of whiplash injury.
- Severe physical disability.
- uncontrolled endocrine disorders (e.g., hyperthyroidism, diabetes); 6) illness (e.g., schizophrenia or substance abuse).
- The use of medication other than as-needed analgesics (excluding long-term narcotics).
- Malignancy.
- Psychiatric disorders.
- A score of ≥ 9 points in the Beck depression inventory.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Pain Intensity Changes from Baseline, and 10 weeks A 10-point Numerical Pain Scale (0: no pain, 10: maximum pain) assesses the intensity of pain.
- Secondary Outcome Measures
Name Time Method Pittsburgh Quality of Sleep Questionnaire Changes from Baseline, and 10 weeks Hospital Anxiety Depression Scale (HADS) Changes from Baseline, and 10 weeks McGill Pain Questionnaire Changes from Baseline, and 10 weeks Pain Pressure Changes from Baseline, and 10 weeks Fibromyalgia Impact Questionnaire (FIQ) Changes from Baseline, and 10 weeks Beck Inventory for Depression Changes from Baseline, and 10 weeks State-Trait Anxiety Inventory (STAI) Changes from Baseline, and 10 weeks Schöber Test Changes from Baseline, and 10 weeks Widespread pain index Changes from Baseline, and 10 weeks Quality of Life (SF-36) Changes from Baseline, and 10 weeks Fatigue Impact Scale Changes from Baseline, and 10 weeks Symptom severity score Changes from Baseline, and 10 weeks Measurement Finger-Floor symptom severity scale
Trial Locations
- Locations (1)
Adelaida María Castro-Sánchez
🇪🇸Almería, Spain
Adelaida María Castro-Sánchez🇪🇸Almería, Spain